This year has created some unique financial challenges, but it's also led to some money-saving opportunities.
Gilead’s remdesivir shows encouraging data in treating COVID-19 patients -- and countries aim to stock up.
These stocks all grew by more than 40% in their most recent quarters.
Collecting benefits won't be as easy for some people anymore.
A small investment in this pharma giant during The Great Recession would have more than doubled.
Investing during a recession is a move that can pay off -- but not for everyone.
Here's why Walmart+ looks like a winner.
You can still make the most of your benefits even if there's a second wave of the pandemic.
Here's how to know if you're ready.
AstraZeneca, Johnson & Johnson, Merck, and Pfizer will also field questions from lawmakers.